HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-MAR-12 4EBV TITLE STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH TITLE 2 NOVEL ALLOSTERIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FADK 1, FOCAL ADHESION KINASE-RELATED NONKINASE, FRNK, COMPND 5 PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 71, PPP1R71, PROTEIN- COMPND 6 TYROSINE KINASE 2, P125FAK, PP125FAK; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2, FAK, FAK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, ALLOSTERIC INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE,D.J.HOSFIELD REVDAT 5 13-SEP-23 4EBV 1 REMARK SEQADV SSBOND REVDAT 4 27-MAR-13 4EBV 1 JRNL REVDAT 3 16-JAN-13 4EBV 1 JRNL REVDAT 2 02-JAN-13 4EBV 1 JRNL REVDAT 1 22-AUG-12 4EBV 0 JRNL AUTH M.IWATANI,H.IWATA,A.OKABE,R.J.SKENE,N.TOMITA,Y.HAYASHI, JRNL AUTH 2 Y.ARAMAKI,D.J.HOSFIELD,A.HORI,A.BABA,H.MIKI JRNL TITL DISCOVERY AND CHARACTERIZATION OF NOVEL ALLOSTERIC FAK JRNL TITL 2 INHIBITORS. JRNL REF EUR.J.MED.CHEM. V. 61 49 2013 JRNL REFN ISSN 0223-5234 JRNL PMID 22819505 JRNL DOI 10.1016/J.EJMECH.2012.06.035 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 26668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1415 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.67 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.71 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1137 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2103 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 243 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23000 REMARK 3 B22 (A**2) : 0.24000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.12000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.124 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.076 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.301 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2204 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2984 ; 1.191 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 260 ; 5.333 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;32.149 ;23.163 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 399 ;12.693 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;21.686 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 329 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1640 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 431 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 413 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1971 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1046 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1155 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 134 ; 0.185 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.120 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 42 ; 0.233 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.242 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1342 ; 1.752 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 513 ; 0.434 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2071 ; 2.328 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 945 ; 1.855 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 816 ; 2.636 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 414 A 700 REMARK 3 ORIGIN FOR THE GROUP (A): -10.9339 0.9242 -18.4967 REMARK 3 T TENSOR REMARK 3 T11: 0.0179 T22: 0.0374 REMARK 3 T33: 0.0087 T12: 0.0192 REMARK 3 T13: -0.0008 T23: 0.0060 REMARK 3 L TENSOR REMARK 3 L11: 0.2479 L22: 0.8679 REMARK 3 L33: 0.5930 L12: 0.2945 REMARK 3 L13: -0.3123 L23: -0.1838 REMARK 3 S TENSOR REMARK 3 S11: -0.0159 S12: -0.0260 S13: -0.0116 REMARK 3 S21: -0.0677 S22: -0.0166 S23: 0.0122 REMARK 3 S31: 0.0432 S32: 0.0855 S33: 0.0326 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4EBV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000071423. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31536 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.19300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1MP8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG4000, 8% 2-PROPANOL, 12% REMARK 280 GLYCEROL, 0.1M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 37.11100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.97700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 37.11100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.97700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 864 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 383 REMARK 465 SER A 384 REMARK 465 TYR A 385 REMARK 465 TYR A 386 REMARK 465 HIS A 387 REMARK 465 HIS A 388 REMARK 465 HIS A 389 REMARK 465 HIS A 390 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 ASP A 393 REMARK 465 TYR A 394 REMARK 465 ASP A 395 REMARK 465 ILE A 396 REMARK 465 PRO A 397 REMARK 465 THR A 398 REMARK 465 THR A 399 REMARK 465 GLU A 400 REMARK 465 ASN A 401 REMARK 465 LEU A 402 REMARK 465 TYR A 403 REMARK 465 PHE A 404 REMARK 465 GLN A 405 REMARK 465 GLY A 406 REMARK 465 ALA A 407 REMARK 465 MET A 408 REMARK 465 GLY A 409 REMARK 465 SER A 568 REMARK 465 ARG A 569 REMARK 465 TYR A 570 REMARK 465 MET A 571 REMARK 465 GLU A 572 REMARK 465 ASP A 573 REMARK 465 SER A 574 REMARK 465 THR A 575 REMARK 465 TYR A 576 REMARK 465 TYR A 577 REMARK 465 LYS A 578 REMARK 465 ALA A 579 REMARK 465 SER A 580 REMARK 465 LYS A 581 REMARK 465 GLY A 582 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 448 84.27 -152.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0O7 A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 702 DBREF 4EBV A 411 686 UNP Q05397 FAK1_HUMAN 411 686 SEQADV 4EBV MET A 383 UNP Q05397 INITIATING METHIONINE SEQADV 4EBV SER A 384 UNP Q05397 EXPRESSION TAG SEQADV 4EBV TYR A 385 UNP Q05397 EXPRESSION TAG SEQADV 4EBV TYR A 386 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 387 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 388 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 389 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 390 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 391 UNP Q05397 EXPRESSION TAG SEQADV 4EBV HIS A 392 UNP Q05397 EXPRESSION TAG SEQADV 4EBV ASP A 393 UNP Q05397 EXPRESSION TAG SEQADV 4EBV TYR A 394 UNP Q05397 EXPRESSION TAG SEQADV 4EBV ASP A 395 UNP Q05397 EXPRESSION TAG SEQADV 4EBV ILE A 396 UNP Q05397 EXPRESSION TAG SEQADV 4EBV PRO A 397 UNP Q05397 EXPRESSION TAG SEQADV 4EBV THR A 398 UNP Q05397 EXPRESSION TAG SEQADV 4EBV THR A 399 UNP Q05397 EXPRESSION TAG SEQADV 4EBV GLU A 400 UNP Q05397 EXPRESSION TAG SEQADV 4EBV ASN A 401 UNP Q05397 EXPRESSION TAG SEQADV 4EBV LEU A 402 UNP Q05397 EXPRESSION TAG SEQADV 4EBV TYR A 403 UNP Q05397 EXPRESSION TAG SEQADV 4EBV PHE A 404 UNP Q05397 EXPRESSION TAG SEQADV 4EBV GLN A 405 UNP Q05397 EXPRESSION TAG SEQADV 4EBV GLY A 406 UNP Q05397 EXPRESSION TAG SEQADV 4EBV ALA A 407 UNP Q05397 EXPRESSION TAG SEQADV 4EBV MET A 408 UNP Q05397 EXPRESSION TAG SEQADV 4EBV GLY A 409 UNP Q05397 EXPRESSION TAG SEQADV 4EBV SER A 410 UNP Q05397 EXPRESSION TAG SEQRES 1 A 304 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 304 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 304 GLY SER SER THR ARG ASP TYR GLU ILE GLN ARG GLU ARG SEQRES 4 A 304 ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE GLY SEQRES 5 A 304 ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN PRO SEQRES 6 A 304 ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS THR SEQRES 7 A 304 SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA LEU SEQRES 8 A 304 THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS LEU SEQRES 9 A 304 ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE MET SEQRES 10 A 304 GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU GLN SEQRES 11 A 304 VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE LEU SEQRES 12 A 304 TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU GLU SEQRES 13 A 304 SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG ASN SEQRES 14 A 304 VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY ASP SEQRES 15 A 304 PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR TYR SEQRES 16 A 304 LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET ALA SEQRES 17 A 304 PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SER SEQRES 18 A 304 ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE LEU SEQRES 19 A 304 MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN ASN SEQRES 20 A 304 ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU PRO SEQRES 21 A 304 MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU MET SEQRES 22 A 304 THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO ARG SEQRES 23 A 304 PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU GLU SEQRES 24 A 304 GLU GLU LYS ALA GLN HET 0O7 A 700 24 HET IPA A 701 4 HET IPA A 702 4 HETNAM 0O7 8-(4-ETHYLPHENYL)-5-METHYL-2,5-DIHYDROPYRAZOLO[4,3- HETNAM 2 0O7 C][2,1]BENZOTHIAZINE 4,4-DIOXIDE HETNAM IPA ISOPROPYL ALCOHOL HETSYN IPA 2-PROPANOL FORMUL 2 0O7 C18 H17 N3 O2 S FORMUL 3 IPA 2(C3 H8 O) FORMUL 5 HOH *243(H2 O) HELIX 1 1 THR A 412 GLU A 416 5 5 HELIX 2 2 GLN A 418 GLU A 420 5 3 HELIX 3 3 SER A 461 GLN A 477 1 17 HELIX 4 4 GLU A 506 ARG A 514 1 9 HELIX 5 5 ASP A 519 LYS A 540 1 22 HELIX 6 6 ASP A 546 ARG A 550 5 5 HELIX 7 7 PRO A 585 MET A 589 5 5 HELIX 8 8 ALA A 590 ARG A 597 1 8 HELIX 9 9 THR A 600 MET A 617 1 18 HELIX 10 10 LYS A 627 ASN A 629 5 3 HELIX 11 11 ASP A 630 ASN A 637 1 8 HELIX 12 12 PRO A 648 TRP A 659 1 12 HELIX 13 13 ASP A 662 ARG A 666 5 5 HELIX 14 14 ARG A 668 ALA A 685 1 18 SHEET 1 A 5 ILE A 422 GLY A 431 0 SHEET 2 A 5 GLY A 434 TYR A 441 -1 O VAL A 436 N ILE A 428 SHEET 3 A 5 LEU A 449 THR A 455 -1 O ILE A 453 N HIS A 437 SHEET 4 A 5 TRP A 496 GLU A 500 -1 O MET A 499 N ALA A 452 SHEET 5 A 5 LEU A 486 ILE A 490 -1 N GLY A 488 O ILE A 498 SHEET 1 B 2 ASN A 551 SER A 556 0 SHEET 2 B 2 CYS A 559 GLY A 563 -1 O LYS A 561 N LEU A 553 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.03 CISPEP 1 ASN A 493 PRO A 494 0 -4.65 SITE 1 AC1 14 MET A 475 LEU A 534 HIS A 544 ARG A 550 SITE 2 AC1 14 ASN A 551 VAL A 552 LEU A 562 GLY A 563 SITE 3 AC1 14 ASP A 604 MET A 607 PHE A 608 CYS A 611 SITE 4 AC1 14 HOH A 888 HOH A 893 SITE 1 AC2 2 ARG A 508 CYS A 611 SITE 1 AC3 6 TRP A 606 VAL A 610 PHE A 623 ARG A 640 SITE 2 AC3 6 LEU A 641 TRP A 659 CRYST1 74.222 47.954 83.281 90.00 112.45 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013473 0.000000 0.005567 0.00000 SCALE2 0.000000 0.020853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012992 0.00000